Explore 9-Me-BC dosage trends, reconstitution volumes, and vial size patterns from anonymized WPA peptide calculator data.
9-Me-BC is a small-molecule β-carboline alkaloid studied in rodent models for dopaminergic and neurogenic activity. It is a chemical compound, not a peptide, so the certificate of analysis (COA) is about chemical purity and identity rather than a peptide sequence.
In rodent ventral mesencephalic primary cultures and in vivo, 9-Me-BC has been reported to stimulate dopaminergic neuron proliferation and survival, upregulate BDNF and GDNF expression, and exert anti-inflammatory effects on microglia. The proximal molecular target has not been settled; weak MAO-A inhibition and partial agonism at β-carboline-sensitive sites have been proposed.[2]
Pre-clinical rodent work has reported neuroprotection in MPTP and 6-OHDA Parkinson's-disease models and procognitive effects in the Morris water maze.[3] No registered human clinical trial has been conducted and the molecule has no pharmaceutical sponsor.
No medicinal-product authorisation in any jurisdiction. **United States:** not FDA-approved; not scheduled by the DEA; sold as a research chemical only. **European Union:** no EMA marketing authorisation and no national medicinal-product approval; falls under each member state's novel-food and research-chemical rules. **Russian Federation:** no Roszdravnadzor medicinal-product registration; not on the Russian formulary. Occurs naturally in trace amounts in coffee, soy sauce, and other fermented foods (food-trace concentrations only; not approved as a food additive or supplement ingredient anywhere). No registered human clinical trial has been conducted.
9-Me-BC has a reported half-life of ~few hours (estimated). The pharmacokinetic reference models an interval of once daily (oral); this is not a measured community cadence or a dosing recommendation. Cleared within hours, so daily dosing acts as a fresh pulse each day rather than building up. Consistent daily timing matters more than the exact amount. Pharmacokinetic source: No human PK data; dopaminergic β-carboline studied only in rodents (Polanski et al. Neurobiol Aging 2010). It is catalogued under Other Peptides on WPA.
4 9-Me-BC reconstitution calculations have been logged by the WPA community.
This is the lifetime header population. Each chart and its associated analysis below use their own selected period and denominator; frequency responses are a separate cohort.
These figures come from anonymized WPA peptide calculator sessions, not verified administrations or unique people. Separate modal inputs do not establish a joint protocol. They are community input statistics — not dosing recommendations, and not medical advice.
These figures come from anonymized WPA peptide calculator sessions.
All figures shown are aggregated from anonymized calculator inputs and are provided strictly for independent laboratory research and educational purposes. They are community usage statistics — not dosing recommendations, and not medical advice.